Maintenance of intestinal Th17 cells and reduced microbial translocation in SIV-infected rhesus macaques treated with interleukin (IL)-21
about
Gut barrier structure, mucosal immunity and intestinal microbiota in the pathogenesis and treatment of HIV infectionReversing Gut Damage in HIV Infection: Using Non-Human Primate Models to Instruct Clinical ResearchIL-21 Signaling in ImmunityNew Insights about Treg and Th17 Cells in HIV Infection and Disease ProgressionHIV therapeutic vaccines: moving towards a functional cureGut Microbiota in HIV Infection: Implication for Disease Progression and ManagementLoss of Function of Intestinal IL-17 and IL-22 Producing Cells Contributes to Inflammation and Viral Persistence in SIV-Infected Rhesus MacaquesIL-21 and probiotic therapy improve Th17 frequencies, microbial translocation, and microbiome in ARV-treated, SIV-infected macaques.CD4 depletion in SIV-infected macaques results in macrophage and microglia infection with rapid turnover of infected cellsComparative Analysis of Immune Activation Markers of CD8(+) T Cells in Lymph Nodes of Different Origins in SIV-Infected Chinese Rhesus MacaquesPerspectives for immunotherapy: which applications might achieve an HIV functional cure?Developments in HIV-1 immunotherapy and therapeutic vaccination.CD4+ T cells contain early extrapulmonary tuberculosis (TB) dissemination and rapid TB progression and sustain multieffector functions of CD8+ T and CD3- lymphocytes: mechanisms of CD4+ T cell immunity.Lipopolysaccharide induces immune activation and SIV replication in rhesus macaques of Chinese origin.The loss of CCR6+ and CD161+ CD4+ T-cell homeostasis contributes to disease progression in SIV-infected rhesus macaques.Early lymphoid responses and germinal center formation correlate with lower viral load set points and better prognosis of simian immunodeficiency virus infection.Using the pathogenic and nonpathogenic nonhuman primate model for studying non-AIDS comorbidities.Impaired Th17 polarization of phenotypically naive CD4(+) T-cells during chronic HIV-1 infection and potential restoration with early ARTTh17 and Th17/Treg ratio at early HIV infection associate with protective HIV-specific CD8(+) T-cell responses and disease progressionMacaque models of enhanced susceptibility to HIV.IL-21 induces antiviral microRNA-29 in CD4 T cells to limit HIV-1 infectionCollapse of Cytolytic Potential in SIV-Specific CD8+ T Cells Following Acute SIV Infection in Rhesus Macaques.Interleukin-21 combined with ART reduces inflammation and viral reservoir in SIV-infected macaquesIdentification of novel HIV-1 dependency factors in primary CCR4(+)CCR6(+)Th17 cells via a genome-wide transcriptional approach.Sex differences in soluble markers vary before and after the initiation of antiretroviral therapy in chronically HIV-infected individuals.Animal models to achieve an HIV cureMolecular and genetic inflammation networks in major human diseases.Antiretroviral Therapy in Simian Immunodeficiency Virus-Infected Sooty Mangabeys: Implications for AIDS PathogenesisHuman Th17 Cells Lack HIV-Inhibitory RNases and Are Highly Permissive to Productive HIV Infection.Immune activation and collateral damage in AIDS pathogenesis.Interleukin-21 and T follicular helper cells in HIV infection: research focus and future perspectives.Interleukin-21: a double-edged sword with therapeutic potential.Serious Non-AIDS Events: Therapeutic Targets of Immune Activation and Chronic Inflammation in HIV InfectionCitrobacter rodentium: a model enteropathogen for understanding the interplay of innate and adaptive components of type 3 immunity.Induction of IL21 in Peripheral T Follicular Helper Cells Is an Indicator of Influenza Vaccine Response in a Previously Vaccinated HIV-Infected Pediatric Cohort.Follicular CD8 T cells accumulate in HIV infection and can kill infected cells in vitro via bispecific antibodies.Differential effects of HIV transmission from monocyte-derived dendritic cells vs. monocytes to IL-17+CD4+ T cells.Mucosal Regulatory T Cells and T Helper 17 Cells in HIV-Associated Immune ActivationIL-21 Therapy Controls Immune Activation and Maintains Antiviral CD8+ T Cell Responses in Acute Simian Immunodeficiency Virus Infection.IL-23 signaling in Th17 cells is inhibited by HIV infection and is not restored by HAART: Implications for persistent immune activation.
P2860
Q26748743-AC0B1398-FF22-4C89-A2BC-7523225C1399Q26765018-ABB30543-DC59-41F4-A2E0-EFE5B9CF3F2FQ26766361-7273B8A4-F87F-4DBC-88B0-F853EFC32020Q26777036-59F54393-DB7E-415F-BDB9-17A5773B079DQ27002180-7493BB11-5799-475C-B6D3-F9BA3C0B5993Q27014742-784E5A01-CE2E-4F0D-90AC-0C71DF5EC3B0Q27316093-E3826D7E-E430-4948-B693-D92BF61353C2Q27320132-FBC7CF8F-5E38-4572-A04B-3E846B1DBC12Q27322949-4457B4D5-6518-4E4F-BEAB-DEDFDD72FC95Q27329088-C92CDF68-D155-4045-AE3B-9469DEEEA8C5Q28078726-DEFF3542-0AA4-4C7A-86F6-FF695EAD8B87Q30364312-F8A11057-CCC9-40B2-A127-BA4BD29765CCQ30584398-94F214D4-8736-44CA-9C7C-5821A927AEC4Q33740405-8E7D9463-A5B9-4CB2-808A-25ABD4901123Q33808773-E12B3F37-C387-45F2-B8E4-596CFCB5F22DQ33855826-D468B593-9039-45A7-99D5-DF89F3EE5B33Q35204909-CCC7BC1C-E9B6-4259-8FBE-EEF2B2DB60BCQ35626699-317A0EA0-4A34-49CE-B5AE-07D8A131CF71Q35769177-07B57320-26CE-4C64-AAF0-D0C4F6A5A3D1Q35776556-A8562EFD-5989-4B71-8867-0140B11E5149Q35785525-DA1821D8-C74E-4B94-AC1C-43CB2A6D5392Q36236434-223AB8EE-DF78-4778-AEF5-FB199398E5F4Q36335882-86FB9657-1749-4617-89EC-23B72745DAF6Q36364264-B4332D97-2AE5-4784-8914-6F9DD5AAF6D6Q36957941-5C1021B7-A884-44E0-AA58-C80295480FA9Q37041160-AD557955-C224-45BE-8FA8-E6C0D0ADFE27Q37114392-C3B7612D-15F2-417F-B5FA-6950CA77B07FQ37174423-837F2685-DF78-47F7-AFF3-BDAFEB897E00Q37182674-23E1E298-C1E4-4149-BC12-E6DF9D170CD1Q37199493-7AE684FE-E756-4B10-93A5-C788ACD68600Q38163422-458CB133-BBCB-433E-A954-5E4FF352A004Q38206058-7DE5014F-95CF-4ADE-8987-F32F189B8564Q38749963-9207CD3A-5C5C-48CB-841F-EBA4C6809553Q39371758-D632FF2C-B549-4029-8FAC-CA634FE9A0FAQ40355338-16D25B8F-6061-48EC-B301-5FCE7069081FQ40366328-95B6169E-ED87-4B43-817E-5A12677C0775Q40573003-4A45DDDA-9163-40C2-918A-BABD84BA6F69Q40625213-83062EA9-8F9A-4EC5-8A2F-7975FCE2C618Q45324829-CAA259A8-0B0C-424B-A9D0-D463DD7C55DDQ45406195-0231BBBB-9C8A-4879-AB1E-C28557D6C868
P2860
Maintenance of intestinal Th17 cells and reduced microbial translocation in SIV-infected rhesus macaques treated with interleukin (IL)-21
description
2013 nî lūn-bûn
@nan
2013 թուականին հրատարակուած գիտական յօդուած
@hyw
2013 թվականին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Maintenance of intestinal Th17 ...... eated with interleukin (IL)-21
@ast
Maintenance of intestinal Th17 ...... eated with interleukin (IL)-21
@en
Maintenance of intestinal Th17 ...... eated with interleukin (IL)-21
@nl
type
label
Maintenance of intestinal Th17 ...... eated with interleukin (IL)-21
@ast
Maintenance of intestinal Th17 ...... eated with interleukin (IL)-21
@en
Maintenance of intestinal Th17 ...... eated with interleukin (IL)-21
@nl
prefLabel
Maintenance of intestinal Th17 ...... eated with interleukin (IL)-21
@ast
Maintenance of intestinal Th17 ...... eated with interleukin (IL)-21
@en
Maintenance of intestinal Th17 ...... eated with interleukin (IL)-21
@nl
P2093
P2860
P3181
P1433
P1476
Maintenance of intestinal Th17 ...... eated with interleukin (IL)-21
@en
P2093
Barbara Cervasi
Benton Lawson
Colleen S McGary
Francois Villinger
Guido Silvestri
Jacob D Estes
James G Else
Kenneth A Rogers
Luca Micci
Mirko Paiardini
P2860
P304
P3181
P356
10.1371/JOURNAL.PPAT.1003471
P407
P577
2013-07-04T00:00:00Z